Sign In
Buy HIMS
$27.51
+0 (+0%)
At Close: Jun 03, 2026
Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now?
10:01am, Friday, 16'th Jan 2026
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
OMCL vs. HIMS: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 13'th Jan 2026
Investors interested in stocks from the Medical Info Systems sector have probably already heard of Omnicell (OMCL) and Hims & Hers Health, Inc. (HIMS). But which of these two stocks presents investors
Why Hims & Hers Health, Inc. (HIMS) Outpaced the Stock Market Today
06:45pm, Monday, 12'th Jan 2026
In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $32.34, indicating a +2.05% shift from the previous trading day.
Hims & Hers Expands Platform-Led Access to Provider-Directed Care
11:02am, Monday, 12'th Jan 2026
HIMS broadens access to provider-led care with new offerings in diagnostics, hormonal health and at-home testing.
Stock Market Live January 12: Justice Investigates Fed Chair Jerome Powell, S&P 500 (VOO) Drops
09:40am, Monday, 12'th Jan 2026
Live Updates Initiating Coverage of Hims and Hers 5 minutes ago Live Evercore ISI analyst Mark Mahaney initiated coverage on Hims and Hers (NYSE: HIMS) stock with an "in line" (i.e., neutral) rating a
Pre-Market Stock Futures: The futures are trading lower on Monday morning after a strong finish to the week on Friday, completing a winning week for investors as all three of the major indices closed
Hims & Hers Health: Capitalizing On Healthcare Innovation
03:14pm, Friday, 09'th Jan 2026
Hims & Hers Health remains a speculative buy for aggressive growth investors, driven by its pivot toward precision medicine and AI-enabled healthcare. Recent volatility stems from regulatory risks, th
Stocks Eye Weekly Wins Amid Upbeat Economic Outlook
12:04pm, Friday, 09'th Jan 2026
Stocks are charging higher after nonfarm payrolls and unemployment data quietly impressed
Hims & Hers Growth Story Has A Lot To Prove In 2026
11:54am, Thursday, 08'th Jan 2026
Hims & Hers is down 50% from all-time highs amid fading momentum in their compounded GLP-1 offerings, while new growth vectors are yet to translate into revenue acceleration. Sequential revenue decele
Hims & Hers Plunges 39.2% in 3 Months: Time to Hold the Stock or Sell?
10:56am, Thursday, 08'th Jan 2026
HIMS expands into Canada and the U.K. while revenue and subscribers grow. However, margins and execution raise concerns.
Hims & Hers: Looking Beyond GLP-1s To The Next Phase Of Global Growth
09:18am, Thursday, 08'th Jan 2026
Hims & Hers Health is significantly undervalued, with the market underestimating its growth potential and international expansion opportunities. Geographical and product expansion, vertical integratio
Hims & Hers Health: Under-Appreciated Upside
03:31pm, Wednesday, 07'th Jan 2026
Hims & Hers Health is aggressively expanding through new product launches, international markets, and strategic acquisitions, supporting a bullish outlook. HIMS targets $6.5 billion in 2030 revenue, l
Hims & Hers: A Rare GARP Setup After The Market Reset
02:26pm, Wednesday, 07'th Jan 2026
Hims & Hers is an asset-light platform. Subscriptions, cross-selling, and personalization drive rising ARPU, strong retention, and improving unit economics with structurally low CAC. Growth has normal
Hims & Hers: Capitalizing On Robust Subscriber/ARPU Growth - Upgraded Buy Rating
09:45am, Wednesday, 07'th Jan 2026
HIMS is upgraded to a speculative Buy after the steep correction, with the cheaper valuations offering a much-needed, improved margin of safety. Robust subscription/ARPU growth, international expansio
Hims & Hers Health, Inc. (HIMS) Rises Higher Than Market: Key Facts
06:46pm, Tuesday, 06'th Jan 2026
Hims & Hers Health, Inc. (HIMS) reached $35.45 at the closing of the latest trading day, reflecting a +2.12% change compared to its last close.
